Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.

Autor: Sant'Anna R; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Gallego P; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Robinson LZ; Molecular and Experimental Medicine Department, The Scripps Research Institute, La Jolla, California, 92037, USA., Pereira-Henriques A; Molecular Neurobiology, IBMC- Instituto de Biologia Molecular e Celular i3S - Instituto de Investigação e Inovação em Saúde and ICBAS- Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal., Ferreira N; Molecular Neurobiology, IBMC- Instituto de Biologia Molecular e Celular i3S - Instituto de Investigação e Inovação em Saúde and ICBAS- Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal., Pinheiro F; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Esperante S; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Pallares I; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Huertas O; SOM-Biotech, Baldiri Reixac 4, Barcelona, 08028, Spain., Almeida MR; Molecular Neurobiology, IBMC- Instituto de Biologia Molecular e Celular i3S - Instituto de Investigação e Inovação em Saúde and ICBAS- Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal., Reixach N; Molecular and Experimental Medicine Department, The Scripps Research Institute, La Jolla, California, 92037, USA., Insa R; SOM-Biotech, Baldiri Reixac 4, Barcelona, 08028, Spain., Velazquez-Campoy A; Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit IQFR-CSIC-BIFI, Universidad de Zaragoza, Zaragoza, 50018, Spain.; Department of Biochemistry and Molecular and Cell Biology, University of Zaragoza, Zaragoza, 50009, Spain.; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, 50009, Spain.; Fundación ARAID, Government of Aragón, Zaragoza, 50003, Spain., Reverter D; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain., Reig N; SOM-Biotech, Baldiri Reixac 4, Barcelona, 08028, Spain. reig@sombiotech.com., Ventura S; Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, 08193, Spain. salvador.ventura@uab.es.

Publikováno v: Nature communications [Nat Commun] 2023 Feb 03; Vol. 14 (1), pp. 582. Date of Electronic Publication: 2023 Feb 03.

Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly.

Autor: Kalmouni, Mona¹ (AUTHOR) mk6153@nyu.edu, Oh, Yujeong¹ (AUTHOR), Alata, Wael¹ (AUTHOR) yo612@nyu.edu, Magzoub, Mazin¹ (AUTHOR) mk6153@nyu.edu

Publikováno v: Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1443. 25p.

Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy.

Autor: Iino, Takuya^1,2, Nagao, Manabu³ mnagao@med.kobe-u.ac.jp, Tanaka, Hidekazu¹, Yoshikawa, Sachiko¹, Asakura, Junko¹, Nishimori, Makoto⁴, Shinohara, Masakazu^4,5, Harada, Amane², Watanabe, Shunsuke⁶, Ishida, Tatsuro^1,7, Hirata, Ken-ichi^1,3, Toh, Ryuji³

Publikováno v: Scientific Reports. 9/3/2024, Vol. 14 Issue 1, p1-9. 9p.

Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?

Autor: Bellofatto IA; Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy., Nikolaou PE; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771, Athens, Greece., Andreadou I; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis, Zografou, 15771, Athens, Greece., Canepa M; Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.; Cardiology Unit, Ospedale Policlinico San Martino IRCCS, Genoa, Italy., Carbone F; Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network, L.Go R. Benzi 10, 16132, Genoa, Italy., Ghigo A; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, Turin, Italy., Heusch G; Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany., Kleinbongard P; Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany., Maack C; Department of Translational Research, Comprehensive Heart Failure Center (CHFC), and Medical Clinic I, University Clinic Würzburg, Würzburg, Germany., Podesser BK; Ludwig Boltzmann Institute for Cardiovascular Research at the Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria., Stamatelopoulos K; Angiology and Endothelial Pathophysiology Unit, Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Stellos K; Department of Cardiovascular Research, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Vilahur G; Research Institute, Hospital de La Santa Creu I Sant Pau, IIB-Sant Pau, C/Sant Antoni Mª Claret 167, 08025, Barcelona, Spain.; CiberCV, Institute Carlos III, Madrid, Spain., Montecucco F; Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network, L.Go R. Benzi 10, 16132, Genoa, Italy., Liberale L; Department of Internal Medicine, University of Genoa, 6 Viale Benedetto XV, 16132, Genoa, Italy. luca.liberale@unige.it.; IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network, L.Go R. Benzi 10, 16132, Genoa, Italy. luca.liberale@unige.it.

Publikováno v: Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.

Transthyretin deposition accelerates the development of experimental osteoarthritis in mice

Autor: Matsuzaki, T. ^†, Alvarez-Garcia, O. ^†, Akasaki, Y. ^‡, Reixach, N. ^†, Buxbaum, J. ^†, Lotz, M.K. ^†

Publikováno v: In Osteoarthritis and Cartilage April 2016 24 Supplement 1:S153-S153